Gamma-butyrolactone-induced dopamine accumulation in prefrontal cortex is affected by tyrosine availability

European Journal of Pharmacology

Volumn 589, Issue 1-3, 2008, Pages 106-109

  Jaskiw, George E ^a,b   Newbould, Erica ^a   Bongiovanni, Rodolfo ^a  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

dopamine; gamma butyrolactone; prefrontal cortex; striatum; tyrosine; tyrosine hydroxylase

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMINO ACID; DOPAMINE; GAMMA BUTYROLACTONE; NEUTRAL AMINO ACID; TYROSINE;

AMINO ACID BRAIN LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; RECEPTOR SENSITIVITY; STRIATE CORTEX;

4-BUTYROLACTONE; ANIMALS; BASAL GANGLIA; DOPAMINE; INJECTIONS, INTRAPERITONEAL; MALE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE; UP-REGULATION;

EID: 47549105098     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.06.018     Document Type: Article

References (27)

1. Bannon M.J., Michaud R.L., and Roth R.H. Mesocortical dopamine neurons: lack of autoreceptors modulating dopamine synthesis. Mol. Pharmacol. 19 (1981) 270-275
2. Bongiovanni R., Kirkbride B., Walmire P., and Jaskiw G.E. Tyrosine administration does not affect desipramine-induced dopamine levels as measured in vivo in prefrontal cortex. Brain Res. 1054 (2005) 203-206
3. Bongiovanni R., Young D., Newbould E., and Jaskiw G.E. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine. Brain Res. 1115 (2006) 26-36
4. Bongiovanni R., Newbould E., and Jaskiw G.E. Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels. Brain Res. 1190 (2008) 39-48
5. Cooper J.R., Bloom F.E., and Roth R.H. The Biochemical Basis of Neuropharmacology. 8th ed. (2002), Oxford University Press, New York
6. Fernstrom J.D., and Fernstrom M.H. Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. J. Nutr. 137 (2007) 1539S-1547S
7. Galloway M.P., Wolf M.E., and Roth R.H. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. J. Pharmacol. Exp. Ther. 236 (1986) 689-698
8. Jaskiw G.E., and Bongiovanni R. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat. Psychopharmacology (Berl.) 172 (2004) 100-107
9. Jaskiw G.E., Simpson C., Bongiovanni R., and Yamamoto B.K. Tyrosine augments clozapine-induced dopamine release in the medial prefrontal cortex of the rat in vivo: effects of access to food. Neurosci. Lett. 357 (2004) 5-8
10. Jaskiw G.E., Kirkbride B., Newbould E., Young D., Durkalski V., and Bongiovanni R. Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion. Psychopharmacology (Berl.) 179 (2005) 713-724
11. Jaskiw G.E., Newbould E., and Bongiovanni R. Tyrosine availability modulates potassium-induced striatal catecholamine efflux in vivo. Brain Res. 1209 (2008) 74-84
12. Kaufman S. Tyrosine hydroxylase. In: Meister A. (Ed). Advances in Enzymology and Related Areas of Molecular Biology vol. 70 (1995), John Wiley & Sons Inc., New York 103-220
13. Lew J.Y., Garcia-Espana A., Lee K.Y., Carr K.D., Goldstein M., Haycock J.W., and Meller E. Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity. Mol. Pharmacol. 55 (1999) 202-209
14. Lindstrom L.H., Gefvert O., Hagberg G., Lundberg T., Bergstrom M., Hartvig P., and Langstrom B. Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by l-(beta-11C) DOPA and PET. Biol. Psychiatry 46 (1999) 681-688
15. McTavish S.F., Cowen P.J., and Sharp T. Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology (Berl.) 141 (1999) 182-188
16. McTavish S.F., McPherson M.H., Harmer C.J., Clark L., Sharp T., Goodwin G.M., and Cowen P.J. Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness. Br. J. Psychiatry 179 (2001) 356-360
17. Milner J.D., and Wurtman R.J. Catecholamine synthesis: physiological coupling to precursor supply. Biochem. Pharmacol. 35 (1986) 875-881
18. Montgomery A.J., McTavish S.F., Cowen P.J., and Grasby P.M. Reduction of brain dopamine concentration with dietary tyrosine plus phenylalanine depletion: an [11C]raclopride PET study. Am. J. Psychiatry 160 (2003) 1887-1889
19. Roth R.H., Walters J.R., and Aghajanian G.K. Effect of impulse flow on the release and synthesis of DA in the rat striatum. In: Usdin E., and Snyder S.H. (Eds). Frontiers in Catecholamine Research (1973), Pergamon Press, New York 567-574
20. Schmitz Y., Benoit-Marand M., Gonon F., and Sulzer D. Presynaptic regulation of dopaminergic neurotransmission. J. Neurochem. 87 (2003) 273-289
21. Sved A.F., and Fernstrom J.D. Tyrosine availability and dopamine synthesis in the striatum: studies with gamma-butyrolactone. Life Sci. 29 (1981) 743-748
22. Walters J.R., and Roth R.H. Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum. Biochem. Pharmacol. 21 (1972) 2111-2121
23. Walters J.R., and Roth R.H. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 296 (1976) 5-14
24. Westerink B.H.C., and Wirix E. On the significance of tyrosine for the synthesis and catabolism of dopamine in rat brain: evaluation by HPLC with electrochemical detection. J. Neurochem. 40 (1983) 758-764
25. Westerink B.H., van Es T.P., and Spaan S.J. Effects of drugs interfering with dopamine and noradrenaline biosynthesis on the endogenous 3,4-dihydroxyphenylalanine levels in rat brain. J. Neurochem. 39 (1982) 44-51
26. Wiesel F.A., Andersson J.L., Westerberg G., Wieselgren I.M., Bjerkenstedt L., Hagenfeldt L., and Langstrom B. Tyrosine transport is regulated differently in patients with schizophrenia. Schizophr. Res. 40 (1999) 37-42
27. Wiesel F.A., Edman G., Flyckt L., Eriksson A., Nyman H., Venizelos N., and Bjerkenstedt L. Kinetics of tyrosine transport and cognitive functioning in schizophrenia. Schizophr. Res. 74 (2005) 81-89